2024 North America Coagulation Testing Market in the US, Canada, Mexico--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies, Latest Technologies, Instrumentation Pipeline

February 2024 | - | ID: 2C7B67B0B716EN
Venture Planning Group

Abstracts

This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget.

The report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.

New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Coagulation Tests Analyzed in the Report

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Country Analyses

Canada, Mexico, USA

Competitive Assessments

• Extensive strategic profiles of major suppliers and emerging market entrants.

Current and Emerging Products

• Review of established and emerging procedures.
• Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

• Analysis of current and emerging technologies and their potential market applications.
• Companies developing or marketing new technologies and products by test.

Strategic Recommendations

• Product development and business expansion opportunities with significant market appeal.
• Ideal product models with tentative prices and operating characteristics.
• Alternative market penetration strategies for instrument and reagent suppliers.
• Potential market entry barriers and risks.

Contents

I. Introduction
II. Market Overview
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Major Routine and Special Coagulation Tests

1. INTRODUCTION


2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)


3. ALPHA-2 ANTIPLASMIN


4. ANTITHROMBIN III


5. BLEEDING TIME


6. D-DIMER


7. ETHANOL FLOCCULATION TEST


8. EUGLOBULIN LYSIS


9. FACTOR ASSAYS

a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII

10. FIBRIN DEGRADATION PRODUCTS


11. FIBRINOGEN


12. HEPARIN


13. HIRUDIN


14. HYPERCOAGULABILITY AND THROMBOSIS


15. LIPOPROTEIN A


16. PLASMIN


17. PLASMINOGEN


18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)


19. PLATELET FUNCTION TESTS


20. PLATELET AGGREGATION


21. PROTEINS C AND S


22. PROTHROMBIN FRAGMENT 1.2


23. PROTHROMBIN TIME (PT)


24. REPTILASE TIME


25. THROMBIN TIME


26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)


27. VON WILLEBRAND'S FACTOR

B. Coagulation Instrumentation Review: Centralized
And POC Testing Analyzers
C. Major Coagulation Testing Technologies
And Their Potential Applications
VIII. Country Market Analyses: Market Size, Reagent and Instrument Sales Forecasts, Volume
Projections for 40 Procedures, Supplier Sales and Market Shares
- Bahrain
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates